Canada’s Lallemand Bio-Ingredients announces an equity investment through its Swiss affiliate, Danstar Ferment AG, in Livzym Biotechnologies, a Turkish company specializing in fungi-based enzymes for industrial use.
With additional equity from Turkish investors, the funds will help finance the expansion of Livzym’s production plant in Tuzla, near Istanbul, to meet the increasing demand for sustainable enzymes across a wide range of industries, including food, textile, paper, animal feed, and biofuels.
“We are committed to making biotechnology one of the answers to the challenges the world faces concerning nutrition, health, and the environment”
Lallemand Bio-Ingredients president Lars Asferg, shares, “We are committed to making biotechnology one of the answers to the challenges the world faces concerning nutrition, health, and the environment. The inclusion of Livzym’s enzymes within Lallemand’s portfolio will enable us to offer our customers an exciting range of high-performance enzymes.”
Strategic collaboration
As part of the strategic collaboration, Lallemand will market and distribute Livzym’s enzymes to a global customer base, facilitating wider access and sales. Livzym is notable for being Turkey’s first industrial enzyme producer, allowing it to serve regions including Europe, Asia, the Middle East, and Africa.
“The future of food and agriculture is vital for global sustainability, with biotechnology playing a key role in transforming production technologies”
Livzym’s enzymes will enhance Lallemand’s existing portfolio, which already features the LallZyme range and acquisitions such as BASF’s Nutrilife food enzymes and Spartec biofuel enzymes.
Recently, in another collaboration targeting the food industry, Lallemand and Dutch ingredient supplier Exter formed a joint venture to develop culinary flavor technologies for the North American market.
Dr. Serdar Uysal, founder and CEO of Livzym, highlights the significance of this partnership in promoting sustainability by leveraging precision fermentation, “The future of food and agriculture is vital for global sustainability, with biotechnology playing a key role in transforming production technologies. We are very excited about our strategic investment partnership with Lallemand, a leading global fermentation company, seeing it as a significant opportunity to advance sustainability in enzyme and alternative protein technologies through our precision fermentation capabilities.”
